Navigation Links
The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
Date:8/21/2007

PLSG Invests $450,000 in Three Companies

PITTSBURGH, Aug. 21 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, announced that the PLSG has invested a total of $450,000 in three companies: Applied Computational Technologies, Separation Design Group and ThermalTherapeutics Systems.

"PLSG is committed to identifying and making investments in promising life sciences technologies," said John W. Manzetti, PLSG's President & CEO. Mr. Manzetti continued, "Applied Computational Technologies (AppCompTech), Separation Design Group (SDG) and ThermalTherapeutics Systems (TTS) are three of the compelling companies that PLSG has been working with through our Concept to Commercialization(TM) model. We are excited to add SDG and TTS as new PLSG investment portfolio companies and we are very pleased to continue our support of AppCompTech's product development efforts to commercialize their technology."

The PLSG's $100,000 investment in Separation Design Group will help SDG create a prototype medical oxygen concentrator while also developing smaller, more robust adsorbents; and reducing or eliminating the moisture from the adsorbent package. This product has the potential to revolutionize the entire portable medical oxygen market and significantly improve patient care.

Currently, available portable oxygen systems are too heavy, too noisy, or do not operate long enough without recharging/refilling to facilitate the prescribed therapy. The SDG product will improve the Portable Oxygen Concentrator (POC) technology and minimize the size of the device, vastly improving a patient's overall quality of life and maintain active lifestyles.

The PLSG's $150,000 investment in Applied Computational Technologies will enable the company to propel their product ProACTive(TM) into the marketplace. ProACTive(TM), is AppCompTech's revolutionary radiation dose calculation engine which enables a new generation of highly accurate, extremely fast treatment planning for full adaptive radiotherapy that can eliminate the accuracy/speed trade-off problem that currently exists in the radiation therapy treatment planning process. Until now, both accuracy and speed could not be reached simultaneously during treatment planning. ProACTive's(TM) increased speed and accuracy can create highly precise individualized treatments that will significantly improve patient quality of life and drastically reduce the potential of the radiation destroying the healthy tissue that surrounds the cancerous tumor.

The PLSG's $200,000 investment in ThermalTherapeutics Systems, Inc. will help with the development of a prototype pump for delivering chemotherapy more effectively. The TTS device will deliver both intraperitoneal chemotherapy (IPC) and intraperitoneal hyperthermic chemotherapy (IPHC) to treat metastastic abdominal cancers regardless of primary site, especially ovarian and colon cancer. No device currently exists which has been specifically designed to treat advanced abdominal cancers. The ability to deliver intraperitoneal hyperthermic treatment for disseminated abdominal cancer, therefore, represents a significant advancement in the treatment for a sizable population of cancer patients; substantially improving the quality of life for those undergoing treatment.

The attention that both IPC and IPHC are receiving for the treatment of ovarian, colon, rectal and additional abdominal cancers creates potential for the TTS product to make an important impact on cancer treatment.

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The PLSG invests in and supports the growth of biosciences companies in southwestern Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the Greater Pittsburgh region. http://www.plsg.com

About Applied Computational Technologies

Applied Computational Technologies, LLC (AppCompTech) is a high-tech software development company formed around its premiere product called ProACTive(TM). ProACTive(TM) is a broad based, patent-pending Particle Transport Simulation technology that is valuable in multiple markets from life sciences to nuclear power. http://www.appcomptech.com

Separation Design Group, LLC

Separation Design Group is an early-stage LLC based in Waynesburg, Pa. SDG has completely re-engineered the small scale oxygen concentrator, developing a proprietary and patent pending technology with components that operate at faster cycle times, resulting in a smaller, lighter, more energy efficient device. SDG's lightweight ambient pressure/temperature oxygen concentrator (LAPTOC) represents a paradigm shift in both form and function from current portable medical oxygen concentrators.

About ThermalTherapeutics Systems, Inc.

ThermalTherapeutics Systems, Inc. (TTS) is developing a specialized pump to enable intraperitoneal chemotherapy (IPC) and intraperitoneal hyperthermic chemotherapy (IPHC) procedures for treating ovarian and other abdominal cancers.

Contact:

Lynn Banaszak Brusco, Pittsburgh Life Sciences Greenhouse

(voice) 412-770-1353


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
2. Perscitus Biosciences secures $250K Commerce loan
3. Wisconsin biosciences rise to the challenge
4. Wisconsin professors elected to National Academy of Sciences
5. Quintessence Biosciences advances cancer drug
6. Quintessence Biosciences names new president
7. InvivoSciences receives NIH grant for heart technology
8. Caden Biosciences may signal critical mass
9. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
10. QBI Life Sciences snags $130,000 NIH grant
11. WARF signs licensing pact with BD Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... The 2017 Colorado Manufacturing Awards ... 30 nominees and well as the first-year award for 2017 Manufacturing Women of ... was hosted by CompanyWeek and Manufacturers Edge, among other sponsors. , The ...
(Date:4/21/2017)... ... April 21, 2017 , ... Frederick ... a range of emerging bio and technology start-ups, is hosting “Celebration Friday” (a ... double event will start with libations and networking at 3:30 p.m. at FITCI’s ...
(Date:4/20/2017)... ... April 20, 2017 , ... USDM Life Sciences , the ... and healthcare industries, is pleased to announce Holger Braemer as Vice President ... Europe GmbH” based in Germany. , Braemer is an integral part of USDM’s ...
(Date:4/20/2017)... ... April 20, 2017 , ... Parallel6™ , the leader ... announced today that they were named one of the 2017 Top 10 eClinical ... developments in the pharmaceutical industry. , “We take pride in honoring Parallel6 as one ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):